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Abstract: 
A large number of putative cis-regulatory sequences have been 
annotated in the human genome, but the genes they control 
remain to be defined. To bridge this gap, we generate maps of 
long-range chromatin interactions centered on 18,943 well-
annotated promoters for protein-coding genes in 27 human 
cell/tissue types. We use this information to infer the target 
genes of 70,329 candidate regulatory elements, and suggest 
potential regulatory function for 27,325 non-coding sequence 
variants associated with 2,117 physiological traits and diseases. 
Integrative analysis of these promoter-centered interactome 
maps reveals widespread enhancer-like promoters involved in 
gene regulation and common molecular pathways underlying 
distinct groups of human traits and diseases. 
Main Text:
Genome-Wide Association Studies (GWAS) have uncovered thousands of 
genetic variants associated with human diseases and phenotypic traits1, 
but molecular characterization of these genetic variants has been 
challenging because they are mostly non-coding and lack clear functional 
annotation. Recent studies have shown that these non-coding variants are
frequently marked by chromatin signatures of cis-regulatory elements 
(cREs) in cells, leading to the hypothesis that a substantial fraction of 
variants may act by affecting transcriptional regulation2,3. To formally test 
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this hypothesis, it is critical to define the target genes of cREs in the 
human genome. However, inferring target genes of cREs based on linear 
genomic sequences is not straightforward, since cREs can regulate non-
adjacent genes over large genomic distances4-7. Such long-range 
regulation can take place because chromatin fibers are folded into a 
higher-order structure in which distant DNA fragments can be juxtaposed 
in space8. Consequently, mapping spatial contacts between DNA has the 
potential to uncover target genes of cREs. To this end, Chromosome 
Conformation Capture (3C) techniques such as 4C-seq, ChIA-PET and Hi-C 
have been developed to determine chromatin interactions in a high 
throughput manner9-15. More recently, Hi-C combined with targeted 
capture and sequencing (capture Hi-C) has emerged as a cost-effective 
method to map chromatin interactions for specific regions at high-
resolution16-25. 
In order to systematically annotate candidate target genes for the cREs in 
the human genome, we performed capture Hi-C experiments (Fig. 1a; 
Extended Data Fig. 1) to interrogate chromatin interactions centered at 
well-annotated human gene promoters for 19,462 protein-coding genes 
(see Methods). We carried out these experiments with 27 human 
cell/tissue types including embryonic stem cells, four early embryonic 
lineages (mesendoderm, mesenchymal stem cell, neural progenitor cells, 
and trophoblast), two primary cell lines (fibroblast cells and 
lymphoblastoid cells), and 20 primary tissue types (hippocampus, 
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dorsolateral prefrontal cortex, esophagus, lung, liver, pancreas, small 
bowel, sigmoid colon, thymus, bladder, adrenal gland, aorta, gastric 
tissue, left heart ventricle, right heart ventricle, right heart atrium, ovary, 
psoas, spleen, and fat) for which reference epigenome maps have 
previously been produced as part of the Epigenome Roadmap project 
(Extended Data Fig. 2a; Supplementary Table 1)26. We designed and 
synthesized 12 capture probes for each promoter, six for each of the 
nearest HindIII restriction sites upstream and downstream of the 
transcription start site (TSS). Among 16,720 promoter-containing HindIII 
restriction DNA fragments, 14,357 (86%) contain a single promoter, but 
the 2,363 remaining HindIII fragments harbor multiple promoters 
(Extended Data Fig. 2b; see Methods). The robustness and the coverage 
of capture probe synthesis were validated by sequencing (Extended Data 
Fig. 2c-f). On average, each capture Hi-C experiment produced 65 million 
unique, on-target paired-end reads, yielding a total of 1.8 billion valid read
pairs, ~30% of which were between DNA fragments >15kb apart 
(Supplementary Table 2). 
To identify the long-range chromatin interactions from the capture Hi-C 
data, two normalization steps were introduced. First, the biases in capture
efficiency of each promoter (Extended Data Fig. 2g, h) were calibrated 
with the variable “capturability” for each DNA fragment, defined as the 
fraction of total read counts mapped to the region, using a β-spline 
regression model (see Methods). Second, significant chromatin 
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interactions were then identified after normalizing against the distance-
dependent background signals (9% and 5% FDR for P-O and P-P 
interactions, respectively) (see Methods). Focusing on the HindIII 
fragments over 15kb away and within 2Mbp of each promoter, we 
determined a total of 892,013 chromatin interactions (431,141 unique 
interacting pairs) in one or more of the 27 human cell/tissue types (Fig. 
1b; Extended Data Fig. 3a; Supplementary Table 3-5). The median 
distance between the interacting DNA pairs was 158kb, which is within a 
similar range of previously reported chromatin loops and eQTL 
associations (Fig. 1c; Supplementary Table 6)10,12,13. The slight discrepancy
between pcHi-C interactions and eQTL-associations may be attributed to 
different experimental approaches, but nevertheless, the two methods 
give complementary information to each other. Between 13% and 45% 
pcHi-C interactions detected in a cell or tissue type were unique to that 
cell/tissue type (Extended Data Fig. 3b). As expected, most of the 
detected chromatin interactions were within Topologically Associating 
Domains (TADs) defined in the corresponding tissue/cell type (Extended 
Data Fig. 3c, d)27,11. 
To demonstrate that pcHi-C could effectively and reproducibly capture 
long-range chromatin interactions as detected by whole genome in situ 
Hi-C, we compared the pcHi-C data with the in situ Hi-C data obtained 
from four distinct biosamples, including two cell lines (IMR90 lung 
fibroblast cell line and GM12878 lymphoblastoid cell line13) and two 
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primary tissues - dorsolateral prefrontal cortex and hippocampus (see 
Methods). Results of pcHi-C experiments accurately recapitulated 
chromatin loops identified from in situ Hi-C assays in all samples, with the 
area under the receiver operating curve (ROC) ranging between 0.84 and 
0.91 (Extended Data Fig. 4a-e) (see Methods). Additionally, we found high 
reproducibility of pcHi-C chromatin interactions between different donors 
(average ROC score = 0.85; the average Spearman’s rank correlation 
between replicates = 0.4; Extended Data Fig. 4f-j; Supplementary Table 7;
see Methods), and between two independent studies (Extended Data Fig. 
4k). The observation that interactions identified in both replicates 
exhibited the strongest interaction signals, while interactions identified in 
one replicate were moderately strong in one replicate, but moderately 
weak in the other replicate (Extended Data Fig. 4l-m), suggests that the 
interactions that are specific to one replicate may be due to under-
sampling of the other replicate.
The chromatin interactome maps allowed us to assign candidate target 
genes for 70,329 putative cREs, defined based on histone H3K27ac 
signals in each tissue/cell type profiled previously26, for 17,295 promoters.
Each promoter was putatively assigned to 25 cREs on average (Extended 
Data Fig. 5a), while 45% of cREs were assigned to one candidate target 
gene (Extended Data Fig. 5b), similar to the previous observation with 
DNase I hypersensitivity analysis across diverse human cell types 28. We 
took advantage of the existing chromatin datasets collected for the same 
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tissue/cell types26, and examined the relationship of the chromatin states 
between the cREs and the target promoters (see Methods). As expected, 
the fragments that extensively interact with multiple promoters were 
often found at active chromatin regions, such as TF binding clusters or 
super enhancer regions (Extended Data Fig. 5c-i; Supplementary Table 8-
10; see Methods)29. Furthermore, integrative analysis with ChromHMM 
model revealed that active promoters interact three times more 
frequently with DNA fragments harboring active enhancers than the 
bivalent promoters (Fig. 1d). On the other hand, the bivalent promoters 
interact five times more frequently with genomic regions associated with 
Polycomb Repressor Complexes than the active promoters (Fig. 1d). 
Further analysis based on a refined 50-chromatin-state ChromHMM model 
for 5 cell lines also supports our conclusion (Extended Data Fig. 6). 
Three lines of evidence demonstrate that the above promoter-centered 
chromatin interactions contain information on regulatory interactions at 
each promoter in the corresponding cell/tissue types. First, we compared 
the chromatin interactions at promoters with regulatory relationships 
inferred from expression quantitative trait loci (eQTL) in 14 matched 
tissue-types that were recently reported by the GTEx consortium (see 
Methods) (Fig. 2a; Extended Data Fig. 7a-c)30. For each tissue and cell 
type, the previously reported eQTLs were highly enriched in the chromatin
interactions identified in the corresponding tissue, with enrichment up to 
five-fold (ovary) (Fig. 2b; Extended Data Fig. 7d and e). A total of 42,627 
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eQTL associations were detected by pcHi-C chromatin interactions, while 
only 21,362 were expected by random chance after controlling for linear 
genomic distances (Supplementary Table 11 and 12). Second, there is 
significant correlation between activities of cis-regulatory sequences and 
the assigned candidate target gene expression across multiple tissues and
cell types, consistent with the purported regulatory relationships. 
Specifically, the histone modification status of H3K27ac of these cREs was
significantly correlated with the promoter H3K27ac levels (KS-test P value 
< 2.2e-16; Extended Data Fig. 7f) and transcription levels of the predicted
target genes (KS-test P value < 2.2e-16; Extended Data Fig. 7g) across 
these tissues/cell types. For example, the POU3F3 gene expression 
(second column in Fig. 2c) was highly correlated with H3K27ac signals in 
the distal cRE (first column in Fig. 2c) connected by a tissue-specific 
chromatin interaction (last column in Fig. 2c). Lastly, cell/tissue-specific 
cRE-promoter pairs connected by pcHi-C interactions are significantly 
associated with active cREs and genes that are specific to the same 
cell/tissue types. For example, hippocampus specific cRE-promoter 
chromatin interactions are significantly associated with active cREs (Fig. 
2d) and highly expressed genes, albeit modest, (Fig. 2e) in hippocampus. 
Significant associations of cell/tissue-specific pcHi-C interactions in active 
cREs and highly expressed genes are found in other cell/tissue types as 
well (Fig. 2f-h, KS-test P value < 2.2e-16, see Methods). The above results,
taken together, strongly suggest that the predicted cRE-promoter pairs 
10
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
19
20
could uncover regulatory relationships between the cRE and target genes 
in diverse tissues and cell types. 
Widespread promoter-promoter (P-P) interactions have been reported in 
cultured mammalian cells and a few primary tissues14,21,31. The promoter-
centered interaction maps obtained from 27 diverse tissues and cell types
allowed us to test whether this is a general phenomenon. Indeed, 
consistent with previous reports, a significant fraction of the chromatin 
interactions was found between two promoters (9%, n = 79,989, Fisher’s 
Exact test p value < 2.2e-16, Extended Data Fig. 8a). The physical 
proximity of these promoters is accompanied by a strikingly high 
correlation in chromatin modification state between the pair of promoters 
across diverse cell/tissue types (Fig. 3a, b). Previously, several promoter 
loci have been shown to function as enhancers to regulate distal genes32-
34. In support of the functional significance of enhancer-like promoters 
identified in the current study, 6,127 eQTLs match P-P interaction pairs, 
while only 2,722 eQTLs were expected by random chance (Fig. 3c; 
Extended Data Fig. 8b-d; Supplementary Table 13 and 14; see Methods). 
For instance, strong chromatin interactions were found between the 
DACT3 and AP2S1 gene promoter regions, and one significant eQTL 
(rs78730097) for DACT3 gene was located in the AP2S1 promoter in the 
dorsolateral prefrontal cortex (Fig. 3d). Notably, this eQTL does not show 
any meaningful genetic association with the adjacent downstream gene 
(AP2S1) or nearby genes, but is exclusively associated with DACT3 
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(Extended Data Fig. 8e), suggesting regulatory potential of the AP2S1 
promoter region in distal DACT3 gene regulation. To validate the function 
of enhancer-like promoters, we deleted 2 core promoter regions, where 
the downstream gene is not expressed but the promoter region shows 
active chromatin marks, using CRISPR-mediated system (Extended Data 
Fig. 8f, g; see Methods). Deletion of the ARIH2OS core promoter resulted 
in marked down-regulation of the distal target gene (FDR adjusted p-value
= 0.02), NCKIPSD, identified by long-range chromatin interactions (Fig. 3e)
with no significant or moderate effect on nearby genes (Extended Data 
Fig. 8h). Importantly, sgRNA-induced mutations in selected eQTLs 
proximal to transcriptional start sites demonstrated significant down-
regulation effect on distal target genes but no significant effect on nearby 
gene expression in H1-hESC (Fig. 3f; Extended Data Fig. 8i; see Methods). 
Our results strongly suggest genome-wide presence of enhancer-like 
promoters in the human genome and provide additional insight into their 
potential function in distal gene regulation.
The above promoter-centered chromatin interaction maps allowed us to 
infer the target genes of sequences harboring disease-associated variants 
and understand the molecular basis of human disease. We focused on 
42,633 putative disease/trait-associated genetic variants from a recent 
public repository of GWAS catalog1. Consistent with previous reports2,35, a 
significant portion of SNPs (30%, Fisher’s Exact test p value < 2.2e-16) 
were found in putative cREs, emphasizing the importance of target gene 
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identification of cREs in functional interpretation of disease associated 
genetic variants. Since the causal SNPs are unknown in most cases, we 
also included SNPs that lie outside the previously defined cREs for further 
analysis. In total, we were able to assign target genes for 27,325 SNPs in 
the list. On average, each SNP was assigned to between 1 and 3 
candidate target genes in each cell/tissue type, with the caveat that the 
precise number of target genes could potentially be affected by the 
modest resolution of our promoter capture strategy and the heterogeneity
of tissue samples (Extended Data Fig. 9a; Supplementary Table 15; see 
Methods). The above maps therefore provided many more predictions of 
disease-associated genes than using the nearest neighbor gene 
predictions alone (one example is provided for the Parkinson disease in 
Extended Data Fig. 9b, c), with only about 8% of the putative target genes
inferred from our promoter-centered chromatin interaction maps were 
found to be the closest gene to the sequence variant (Extended Data Fig. 
9d). To evaluate the validity of target predictions based on the promoter-
centered chromatin interaction maps, we focused on 7 GWAS variants 
that overlap with previously annotated cREs and eQTLs in human 
lymphoblastoid cell line GM12878 cells. We introduced deletions to these 
elements in GM12878 using CRISPR-Cas9 genome editing tools and 
examined the expression of predicted target genes using RT-qPCR in the 
mutant cells and controls. For 5 of the 7 tested cREs, genetic perturbation 
led to down regulation of the predicted distal target genes (Fig. 4a and 
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Extended Data Fig. 9e-f). This result supports the target gene predictions 
based on the pcHi-C interactions.  
Many diseases and traits could be linked to common molecular pathways, 
and the identification of these shared molecular pathways can be 
beneficial in understanding disease pathogenesis and developing 
treatment. To uncover the common molecular pathways underlying 
different diseases and physiological traits, we first determined the 
diseases/traits that share a significant number of common target genes 
predicted from their respective GWAS-associated SNPs. We grouped 687 
traits and diseases into 40 clusters (Fig. 4b; Extended Data Fig. 10a-c; 
Supplementary Table 16; see Methods). Many physiological traits with 
known connections are found to be clustered together. For examples, C5 
clusters oxygen transport related traits together, C6 groups together traits
related to renal functions, and C20 includes vascular function associated 
traits (Fig. 4b). The above grouping is made possible thanks to the 
promoter-centered chromatin interactome maps, because the similarities 
among related traits observed in Fig. 4b were much less evident when we 
used either GWAS SNPs or nearest genes of the GWAS SNPs to compute 
the similarities as control experiments (Fig. 4c, d, Extended Data Fig. 
10d). Our result suggests the power of target gene identification of GWAS 
variants to uncover trait-trait associations.
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To further understand the common molecular pathways affected in 
various human diseases, we carried out gene ontology (GO) analysis for 
the predicted target genes of the GWAS SNPs within each cluster 
(Supplementary Table 17; see Methods). The enriched GO biological 
processes suggest potential shared molecular pathways for disease and 
trait types in each cluster (Fig. 4e, Extended Data Fig. 10e, 
Supplementary Table 18), including unexpected connections between 
specific traits. For example, C39 exposes a link between the susceptibility 
to infectious and autoimmune diseases and the risk of chemotherapeutic 
toxicity by carboplatin and cisplatin. In support of such link, a putative 
target gene associated with the response to carboplatin and cisplatin is 
ABCF1, which is involved in inflammatory response36. While speculative, 
the shared molecular pathways uncovered by our analyses may provide 
new leads for investigation of the molecular basis of complex traits and 
disease phenotypes. 
In summary, we have generated promoter-centered chromatin 
interactome maps across diverse human cell/tissue types. Our analysis 
covers a broad range of human tissue types and provides prediction of 
target genes for over 70,000 putative cis-regulatory elements and 27,000 
GWAS SNP variants. This resource enables a new approach to 
understanding the molecular pathways dysregulated in distinct diseases 
and traits21. In future studies, delineation of disease-specific chromatin 
interactions with clinical samples by comparing our reference chromatin 
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interaction maps could greatly improve the functional interpretation of 
many disease and trait associated genetic variants. 
It should be noted that the current study only surveys a limited number of
human tissues and cell types, and assigned target genes for a small 
fraction of the putative cis-regulatory elements annotated in the human 
genome. Furthermore, the heterogeneous nature of the tissue samples 
used in this study prevents us from accessing the cell types in which the 
identified chromatin interactions occur, except for a few cell lines. 
Nevertheless, this resource lays the ground for further understanding of 
human disease pathogenesis and development of new treatment 
strategies.
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Methods
Human tissue samples
Esophagus, lung, liver, pancreas, small bowel, sigmoid colon, thymus, 
bladder, adrenal gland, aorta, gastric, left heart ventricle, right heart 
ventricle, right heart atrium, ovary, psoas, spleen, and fat tissues were 
obtained from deceased donors at the time of organ procurement at 
Barnes-Jewish Hospital (St. Louis, USA) as described in our previous 
study26. The same tissue types from different donors were combined 
together during downstream data analysis. Human dorsolateral prefrontal 
cortex (DLPFC rep1) and hippocampus (HC rep1) tissues were obtained 
from the National Institute of Child Health and Human Development 
(NICHD) Brain Bank for Developmental Disorders. These two samples were
from a healthy 31-year-old male donor. Ethics approval was obtained from
the University Health Network and The Hospital for Sick Children for the 
use of these tissues. Another set of human dorsolateral prefrontal cortex 
(DLPFC rep2) and hippocampus (HC rep2) tissues were obtained from the 
Shiley-Marcos Alzheimer's Disease Research Center (ADRC). These two 
samples were from a healthy 80-year-old female donor. Institutional 
Review Board (IRB) approval was obtained from KAIST for the use of these
tissues.
Hi-C library on human tissue samples and early embryonic cell 
types
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Human tissue samples were flash frozen and pulverized prior to 
formaldehyde cross-linking. Fibroblasts (IMR90) and lymphoblastoid cell 
lines (GM12878 and GM19240) were cultured and 5 million cells were 
formaldehyde cross-linked for each Hi-C library. Hi-C was then conducted 
on the samples as previously described, using HindIII for Hi-C library 
preparation37. Previously constructed Hi-C libraries11 were used for human 
ES cells (H1) and early embryonic cell types including mesendoderm, 
mesenchymal stem cell, neural progenitor cells, and trophoblast-like cells.
Generation of capture RNA probes 
In order to perform Promoter Capture Hi-C, we computationally designed 
RNA probes that capture promoter regions of previously annotated human
protein coding genes. Capture regions were selected for 19,462 well-
annotated protein coding gene promoters across 22 autosomes and X 
chromosome according to GENCODE v19 annotation with confidence level 
1 and 2. The annotation confidence level 1 and 2 comprise of genes that 
are accurately annotated with sufficient validation and manual annotation 
by combining the manual gene annotation from the Human and 
Vertebrate Analysis and Annotation (HAVANA) group, automatic gene 
annotation from Ensembl, and validating by CAGE. Due to the variability 
of capture efficiency, 19,328 promoter regions (99%) were captured in 
this study. Among them, 18,943 promoter regions were involved in pcHi-C
interactions in one or more cell/tissue types analyzed in this study. For 
each transcription start site, the two nearest left hand- and right hand-
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side HindIII restriction sites were selected. Six capture oligos were 
designed to be of 120 nucleotide (nt) length and to have 30nt tiling 
overhang. Oligos were designed +/- 300bp upstream and downstream of 
each restriction site. As two restriction sites were chosen for each 
transcription start site, a total of 12 capture oligos were designed to 
target each promoter region. Capture sequences that overlap with directly
adjacent HindIII restriction sites were removed. GC contents of 94% 
capture sequences ranged from 25% to 65%. Some promoters shared the 
same HindIII fragment with at least one other, while 14,357 HindIII 
fragments (86%) were uniquely assigned to one promoter. The effect of 
the DNA fragments harboring multiple promoters on the quality of our 
analytical findings is modest because only 15% of pcHi-C interactions 
emanated from the promoter sharing DNA fragments, and eliminating 
these fragments results in no significant changes in our conclusion for 
both eQTL enrichment test and gene set enrichment analysis. Further, 
strong correlation of GWAS trait associations remains even after excluding
unresolvable promoters. In total, our capture oligo design generated 
280,445 unique probe sequences including randomly selected capture 
regions (i.e. gene deserts). Single-stranded DNA oligos were then 
synthesized by CustomArray Inc. Single-stranded DNA oligos contained 
universal forward and reverse primer sequences (total length 31nt), 
whereby the forward priming sequence contained a truncated SP6 
recognition sequence that was completed by the overhanging forward 
primer during PCR amplification of the oligos. After PCR, double-stranded 
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DNA was converted into biotinylated RNA probes through in vitro 
transcription with the SP6 Megascript kit and in the presence of a 
biotinylated UTP, as previously described11. 
Promoter Capture Hi-C library construction
Promoter Capture Hi-C library was constructed by performing target 
enrichment protocol (enriching target promoter-centered proximity 
ligation fragments from Hi-C library using capture RNA probes). Briefly, we
incubated 500ng Hi-C library for 24h at 65°C in a humidified hybridization 
chamber with 2.5ug human Cot-1 DNA (Life Technologies), 2.5ug salmon 
sperm DNA (Life Technologies), and p5/p7 blocking oligos with 
hybridization buffer mix (10X SSPE, 10mM EDTA, 10X Denhardts solution, 
and 0.26% SDS) and 500ng RNA probes. RNA:DNA hybrids were enriched 
using 50ul T1 streptavidin beads (Invitrogen) through 30min incubation at 
RT. Next, bead-bound hybrids were washed through a 15min incubation in
wash buffer1 (1X SSC and 0.1% SDS) with frequent vortexing, and then 
washed three times with 500ul of pre-warmed (65 °C) wash buffer2 (0.1X 
SSC and 0.1% SDS), then finally resuspended in nuclease-free water. The 
resulting capture Hi-C libraries were amplified while bound to T1 beads, 
and purified using AMPure XP beads, followed by sequencing. 
Promoter Capture Hi-C library sequencing, read alignment, and 
off-target read filtering
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Promoter Capture Hi-C library sequencing procedures were carried out as 
previously described according to Illumina HiSeq2500 or HiSeq4000 
protocols with minor modifications (Illumina, San Diego, CA). Read pairs 
from Promoter Capture Hi-C library were independently mapped to human
genome hg19 using BWA-mem and manually paired with in house script. 
Unmapped, non-uniquely mapped, and PCR duplicate reads were 
removed. Trans-chromosomal read pairs and putative self-ligated 
products (<15kb read pairs) were also removed. Off-target reads were 
removed when both read pairs did not match the capture probe 
sequences. The resulting on-target rates in Promoter Capture Hi-C library 
ranged from 17% to 44% after removing PCR duplicate reads. 
Promoter Capture Hi-C normalization 
Interaction frequencies obtained from Promoter Capture Hi-C were 
normalized in terms of DNA fragment resolution restricted by HindIII. We 
defined DNA fragments that spanned each HindIII restriction site. The 
start and the end of DNA fragments were defined by taking the midpoint 
of adjacent upstream and downstream restriction sites, respectively. We 
merged adjacent DNA fragments if the total length of the DNA fragments 
was less than 3kb. As a result, 510,045 DNA fragments were defined with 
a median length of 4.8kb. After that, we calculated raw interaction 
frequencies at DNA fragment resolution and performed normalization to 
remove experimental biases caused by intrinsic DNA sequence biases (GC
contents, mappability, and effective fragment lengths), RNA probe 
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synthesis efficiency bias, and RNA probe hybridization efficiency bias. 
Highly variable RNA probe synthesis efficiency would greatly complicate 
the control of experimental bias. However, if the efficiency bias was 
reproducible, the bias can be computationally removed. To prove such 
bias reproducibility, we performed RNA-seq with two sets of RNA probes 
that were synthesized independently. The RNA-seq results can 
quantitatively measure the amount of synthesized RNA probes, which is 
an indicator of the probe synthesis efficiency. We observed highly 
reproducible RNA-seq results (Pearson Correlation Coefficient = 0.98), 
indicating reproducible probe synthesis efficiency. To address the high 
complexity of different types of experimental biases, we defined a new 
term named “Capturability”, which refers to the probability of the region 
being captured. We assumed that “Capturability” represents all combined 
experimental biases and can be estimated by the total number of capture 
reads spanning a given DNA fragment divided by the total number of 
captured reads in cis. We found that “Capturability” in each DNA fragment
is highly reproducible across samples with 0.95 Pearson correlation 
coefficient between samples on average. Therefore, we defined universal 
“Capturability” as the summation of all “Capturability” defined in each 
sample and normalized raw interaction frequencies by considering 
“Capturability” of two DNA fragments. During normalization, we processed
promoter-promoter interactions and promoter-other interactions 
independently because promoter regions tend to show very high 
“Capturability” as our capture probes were designed to target promoter 
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regions. Also, we only considered promoter-centered long-range 
interactions over 15kb and within 2Mb from TSS of each gene. We 
denoted Yij to represent the raw interaction frequency between DNA 
fragment i and j and C i to represent “Capturability” defined in DNA 
fragment i. We assumed Yij to follow a negative binomial distribution with 
mean μ and variance μ+αμ2. Here, α > 0 is a parameter to measure the 
magnitude of over-dispersion. We then fitted a negative binomial 
regression model as follows: loguij=β0+β1BS (C¿¿ i)+β2BS(C j)¿, where uijis 
an raw interaction frequency between DNA fragment i and j with coverage
C i and C j and defined the residual R ij=Y ij /exp¿¿ as a normalized 
interaction frequency between DNA fragments i and j. BS represents a 
basis vector obtained from B-spline regression, which applied to a vector 
of values of input variable, C, during negative binomial regression model 
fitting for robustness and memory efficient calculation. 
Identification of P-P and P-O pcHi-C long-range chromatin 
interactions
To identify significant pcHi-C chromatin interactions, we removed distance
dependent background signals from normalized interaction frequencies. 
Here, we assumed that normalized interaction frequency R ijfollows a 
negative binomial distribution with mean μ and variance μ+αμ2. Similar to
the interaction frequency normalization step above, we calculated the 
expected interaction frequency at a given distance by fitting it to a 
negative binomial regression model with basis vectors obtained from B-
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spline regression of distance between two DNA fragments. We denoted Ed 
to represent the expected interaction frequency at a given distance d 
calculated from a negative binomial regression model. Distance 
dependent background signals were removed by taking signal to 
background ratio as follows: (Rij + avg(R)) / (Ed + avg(R)), where d 
indicates distance between DNA fragment i and j. We confirm that the 
average of normalized interaction frequencies against distance dependent
background signals are close to one in all distance, indicating the 
successful elimination of distance dependent background signals using 
our method. Next, using ‘fitDistr’ function in propagate R package we 
found that 3-parmeter Weibull distribution well follows the values of 
normalized interaction frequencies. Thus, we modeled background 
distribution of distance normalized interaction frequencies with 3-
parmeter Weibull distribution. Based on this, significant long-range 
chromatin interactions are defined when observed interaction frequencies 
show lower than 0.01 p-value thresholds by fitting distance background 
removed interaction frequencies with 3-parameter Weibull distribution. To
eliminate false pcHi-C interactions caused by experimental noise, we 
applied the criteria of minimum raw interaction frequencies (having more 
than 5 raw interaction frequencies), which is chosen by investigating 
reproducibility between biological replicates using lymphoblastoid and 
mesenchymal stem cell. Note that as the interaction frequencies in pcHi-C
are mostly zeros or close to zero, the distribution of p-values does not 
follow the uniform distribution, violating the basic assumption of FDR 
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calculation, which assumes that the null distribution follows uniform (0,1) 
distribution. Thus, we simulated normalized interaction frequencies that 
follow 3-parameter Weibull distribution in a sample specific manner, and 
computed the estimated FDR through multiple permutations. The 
estimated FDR through multiple permutation (n=1,000) for P-O and P-P 
pcHi-C interactions is 9% and 5% on average, respectively 
in situ Hi-C experiments and validation of pcHi-C long-range 
chromatin interactions
The visual inspection of normalized interaction frequencies between 
IMR90 Promoter Capture Hi-C and high resolution IMR90 Hi-C showed high
consistency based on manual inspection despite pcHi-C having only 10% 
sequencing depth compared to high resolution Hi-C (Extended Data Fig. 
4a). Next, we compared the identified pcHi-C interactions with “loops” 
defined from IMR90, GM12878, dorsolateral prefrontal cortex, and 
hippocampus tissues using in situ Hi-C experiments (Extended Data Fig. 
4b-e). Although there is a huge discrepancy between the number of in situ
Hi-C loops and pcHi-C interactions, we may consider ‘loops’ are a subset 
of high confident long-range chromatin interactions that involve ‘loop’ 
domains but cannot cover all promoter-mediated long-range chromatin 
interactions. Loops of IMR90 and GM12878 in situ Hi-C result were 
obtained from previous publication13. Loops of dorsolateral prefrontal 
cortex and hippocampus were identified using HiCCUPS, distributed with 
Juicer v1.7.613. The loops were called from Knight-Ruiz normalized 5kb, 
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10kb, and 25kb resolution data, as these parameters were suggested for a
medium resolution Hi-C map by the authors of HiCCUPS. As a result, 7,722
and 8,040 loops were identified from dorsolateral prefrontal cortex and 
hippocampus, respectively. We compared the identified pcHi-C long-range
chromatin interactions to loops of in situ Hi-C data and measured the 
reproducibility in terms of ROC curve (receiver operating characteristic 
curve), a plot of the true positive rate against the false positive rate at 
various threshold settings. Here, we set loops as true interactions. We 
ranked all tested pcHi-C DNA fragment pairs in terms of p-values and then
calculated the fraction of true positive and false positive to draw ROC 
curve. We only considered “loops” emanating from promoter-containing 
DNA fragments defined in our Promoter Capture Hi-C result. Each point on
the ROC curve indicates the true and false positive rate for each 1,000 
false positive interactions. The area under the ROC curve is defined as an 
ROC score and an ROC score of 1 indicates that the rank of DNA fragment 
pairs matched by loops are always higher than all other tested DNA 
fragment pairs according to pcHi-C interaction p-values. 
Reproducibility of pcHi-C chromatin interactions between 
biological replicates
The reproducibility of pcHi-C chromatin interactions between biological 
replicates were measured in terms of ROC curve (Extended Data Fig. 4f). 
Here, we set pcHi-C interactions identified in one replicate as true 
interactions. For the other replicate, we ranked all tested DNA fragment 
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pairs in terms of p-values and then calculated the fraction of true positive 
and false positive to draw ROC curve. The area under the ROC curve is 
defined as an ROC score and an ROC score of 1 indicates that the rank of 
all pcHi-C interactions identified in one replicate is always higher than all 
other tested DNA fragment pairs in another replicate. Due to different 
sequencing depths in each replicate, we first defined true interaction sets 
with one replicate that identified fewer number of pcHi-C interactions than
the other replicate, then tested how these true interactions were well 
detected in the other replicate. Both P-P and P-O interactions were 
combined together for calculating ROC scores. Each dot in ROC curve 
indicates the true positive rate at the corresponding false positive rate 
with increment of 1% of false positive rate. We tested biological replicates
in the following 12 tissue/cell types: aorta (AO2/AO3, ROC score=0.79), 
lung (LG1/LG2, ROC score=0.80), small bowel (SB1/SB2, ROC 
score=0.83), spleen (SX1/SX3, ROC score=0.80), dorsolateral prefrontal 
cortex (FC_rep1/FC_rep2, ROC score=0.92), left ventricle (LV1/LV3, ROC 
score=0.85), mesenchymal stem cell (MSC_rep1/MSC_rep2, ROC 
Score=0.99), hippocampus (HC_rep1/HC_rep2, ROC score=0.81), gastric 
(GA2/GA3, ROC score=0.91), lymphoblastoid cell lines 
(GM12878/GM19240, ROC score=0.98), right ventricle (RV1/RV3, ROC 
Score=0.83), and pancreas (PA2/PA3, ROC score=0.73). Indeed, we 
calculated Spearman’s rank correlation of p values between replicates and
found that the average Spearman’s rank correlation was around 0.40.
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Enrichment of pcHi-C interactions regarding TAD, boundary, and 
unorganized regions
The TAD annotations for 22 samples by DomainCaller14 with 2MB windows 
size were downloaded from the 3DIV database38. The regions between 
TADs were classified as “unorganized” when the gap is longer than 400kb,
otherwise, the remaining regions were classified as “boundary”. Then, the
types of pcHi-C interactions were classified based on the location of DNA 
fragment’s centroid. 
1. “Within TAD”, if both fragments’ centroids are located in the 
identical TAD.
2. “Within unorganized region”, if both fragments’ centroids are 
located in the identical unorganized region.
3. “Between different TADs”, if one fragment’s centroid is located in a 
TAD while another fragment’s centroid is located in a different TAD.
4. “Between TAD and boundary”, if one fragment’s centroid is located 
in a TAD while another fragment’s centroid is covered by boundary 
region.
5. “Between TAD and unorganized region”, if one fragment’s centroid 
is located in a TAD while another fragment’s centroid is located in 
an unorganized region.
Annotation of ChromHMM 18-chromatin state to DNA fragments
The pre-calculated chromatin state annotations were downloaded from 
the 18-state ChromHMM model established by Roadmap Epigenomics 
Project. As the genomic proportion of promoter and enhancer regions are 
relatively low, we assigned the chromatin states to DNA fragments based 
on the following priority order (TssA-EnhA1-EnhA2-TssFlnk-TssFlnkU-
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TssflnkD-EnhG1/G2-EnhWk-TssBiv-Enhbiv). For instance, the chromatin 
state of a fragment was assigned as TssFlnkU, if the fragment contained 
two annotations TssFlnkU and EnhWk. EnhG1 and EnhG2 annotations 
were merged because of their low occurrence percentage. We considered 
two promoter types (TssA and TssBiv) according to ChromHMM 
annotations and investigated the preference of their interacting partners. 
For each promoter type, the occurrence of each chromatin status at 
interacting DNA fragments was divided by the total number of interacting 
DNA fragments. This fraction value of each chromatin status was 
normalized against the genomic fraction of each chromatin status. KS-test
was performed to measure the statistical significance of each chromatin 
status at interacting DNA fragments between TssA and TssBiv promoters.
Analysis with a 50-chromatin-state ChromHMM model
To supplement our analysis with the ChromHMM 18-chromatin state 
model, we conducted in-depth investigations with 5 samples, including H1
embryonic stem cell, mesendoderm, mesenchymal stem cell, trophoblast, 
and IMR90, using a 50-state ChromHMM model produced by the Roadmap 
Epigenomics Project35. The ChromHMM model utilized combination of 29 
chromatin marks to generate a 50-state ChromHMM model. To be 
consistent with the 18-state ChromHMM model, we used the same 
definition for TssA and TssBiv promoter containing fragments, but 
chromatin state of their interacting partners was further refined using the 
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50-state ChromHMM model. The statistical test was performed as 
described in the analysis with the 18-chromatin-state ChromHMM model. 
Identification of extensively interacting DNA fragments
In order to identify DNA fragments that showed extensive long-range 
interactions with multiple promoters, we systematically defined these 
promiscuously interacting DNA fragments from P-P pcHi-C interaction 
maps and P-O pcHi-C interaction maps, respectively. For each cell or 
tissue-type, we selected frequently interacting DNA fragments with 
multiple promoters in terms of 0.01 Poisson p value cutoff. 
Identification of TF clusters in H1-hESC and GM12878
Transcription factor ChIP-seq datasets on human lymphoblastoid cell lines 
(GM12878) and human embryonic stem cell (H1-hESC) were collected 
from ENCODE. These ChIP-seq reads were aligned against human genome
hg19 using BWA-mem with default parameters. Non-uniquely mapped, 
low quality (MAPQ<10), and PCR duplicate reads were removed. Peak 
calling of individual ChIP-seq experiments was performed with MACS2 
callpeak with default parameters 39. We defined TF clusters by calling 
peaks from combined bed files of TF peaked regions using MACS2 
bdgpeakcall. The regions occupied by multiple TF peaks were recognized 
as TF clusters. To remove parameter dependent bias, we retrieved TF 
clusters 40 times with various parameter sets as following; minimum # of 
TFs within cluster (5 or 10), minimum length of cluster from 100bp to 
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1600bp, and maximum gap length within cluster from 100bp to 51.2kb. 
Final TF clusters were defined when the region was detected as TF 
clusters more than 50 times from 100 different parameter sets. 
Enrichment analysis of TF clusters and super-enhancers
In order to calculate the enrichment of TF clusters or super-enhancers at 
extensively interacting DNA fragments (EIF), we counted the number of 
matched TF clusters and super-enhancers. The list of super-enhancers 
was obtained from the 3DIV database38. Permutation test was performed 
to calculate the expected values. Using Bedtools shuffleBed, we 
generated random genomic locations that resemble actual TF clusters 
with the same size but different genomic coordinates. Bedtools 
intersectBed identified any overlap between EIF and TF clusters or random
genomic locations. Standard deviations of error bars in the random 
genomic locations were calculated from 10,000 random data sets. In order
to test the enrichment of TF clusters compared to typical TF peaks, we 
generated random genomic locations that resemble actual TF clusters 
with the same size but different genomic coordinates matched to typical 
TF peaks. Standard deviations of error bars in the typical TF peaks were 
calculated from 10,000 random data sets. Similarly, enrichment analysis 
of super-enhancers was conducted by generating random genomic 
locations of the same size as super-enhancers but at different genomic 
coordinates. We also conducted the enrichment test with typical 
enhancers. We revealed that P-O EIFs highly co-exist with super-enhancer 
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regions, rather than typical enhancers and genomic background for most 
of the samples, except two samples, lymphoblastoid cell lines and gastric 
tissue. Note that half of lymphoblastoid P-O EIFs are co-occupied with 
typical enhancers that are classified as super-enhancers in other 
cell/tissue types.
Comparison between eQTL associations and P-O interactions
In order to test the enrichment for P-O pcHi-C chromatin interactions in 
significant eQTL associations, we compared P-O pcHi-C interactions to 
significant eQTL associations in the matching tissue types. The eQTL 
associations were downloaded directly from GTEx Portal (downloaded on 
Nov. 10th, 2017) for all matching tissue types (n=14, adrenal gland, aorta, 
dorsolateral prefrontal cortex, brain hippocampus, sigmoid colon, 
esophagus, left heart ventricle, liver, lung, ovary, pancreas, small 
intestine terminal ileum for small bowel, spleen, and stomach for gastric). 
First, the significant eQTLs defined by GTEx (q-value ≤ 0.05) were filtered 
so that only the eQTL variants within the fragments that involve P-O pcHi-
C interactions remain for comparison. Then, we removed pcHi-C 
interactions beyond 1Mb in distance to match the range of eQTL 
association, and discarded eQTL associations with distance below 15kb to 
match the valid interaction cutoff. The filtered, significant eQTL 
associations were compared with pcHi-C and randomized interactions in 
the same condition. Here, we only considered P-O pcHi-C interactions with
DNA fragments that do not harbor multiple promoters. For the random 
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expectation, we generated a simulated pcHi-C interaction pool by creating
all possible combinations of DNA fragments with no TSS and the protein 
coding genes that exist within the distance range. The pcHi-C interactions 
that exist in any of the tissue/cell type were removed from the control 
interaction pool for the enrichment analysis. To avoid variation caused by 
the difference in distance between pcHi-C interactions and eQTL 
associations, we created distance matched control, in which the number 
of pcHi-C interactions was stored at the interval of 40kb, and the same 
number of interactions was drawn randomly from the control interaction 
pool. The number of randomized interactions drawn from each 
chromosome was matched to the pcHi-C interactions. The standard 
deviation was obtained by permuting the random expectation with 1,000 
iterations and was used to calculate the statistical confidence
To illustrate the filtering process of the eQTL data, for example, the 
549,763 significant eQTLs in adrenal gland were reduced to 237,181 after 
collecting eQTLs located in the DNA fragments without TSS and discarding
eQTL association with the distance below 15kb and with a pseudogene 
target. This filtered set of significant eQTL associations was used for 
enrichment test for both pcHi-C and randomized interactions. The number 
of total tested significant eQTL association, 19,996 in case of adrenal 
gland, in Supplementary Table 11, indicates the number of significant 
eQTLs located in the DNA fragments that are associated with the pcHi-C 
interactions in the corresponding cell/tissue type.
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Variations in H3K27ac signals at promoters and cREs connected 
by P-O interactions
We conducted correlation analysis of H3K27ac signals across all available 
cell/tissue types for each promoter-cRE pair connected by P-O interactions
in at least one cell/tissue type analyzed. First, we defined putative distal 
cis-regulatory elements (cREs) marked by H3K27ac peaks across all 27 
cell/tissue types. We merged these elements if the peaks are within 3kb of
each other, then we defined cRE-containing DNA fragment when the DNA 
fragment harbors at least one cis-regulatory element. When a DNA 
fragment contained both TSS and cRE, we defined the fragment as a 
promoter-containing DNA fragment instead of a cRE-containing DNA 
fragment because our experiment is designed to target promoter regions. 
We used input normalized H3K27ac RPKM values by taking log2 
transformation as H3K27ac signals at promoters and cREs. Pearson 
correlation coefficient values were calculated for each promoter-cRE pair 
connected by pcHi-C interactions after excluding cREs spanning adjacent 
DNA fragments and visualized as a box plot. Random expectation values 
were calculated after randomization of H3k27ac signals at promoters and 
cREs. Distance matching random expectation values were calculated after
random selection of cRE-promoter pairs by controlling distance 
information as same as identified cRE-promoter pairs.  
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Analysis of H3K27ac signals at cREs and expression of target 
genes connected by cell/tissue specific cRE-promoter pairs
In order to investigate cell/tissue-specific cRE-promoter pairs, for each 
cell/tissue-type unique cRE-promoter pairs were collected and then 
distance normalized pcHi-C interaction frequencies of corresponding P-O 
pcHi-C interactions were obtained across all cell/tissue types. We only 
considered a unique P-O interaction pair when multiple cREs are located in
a same DNA fragment and target a same promoter. The cell/tissue-
specific cRE-promoter pairs exhibit strong enrichment of pcHi-C 
interaction frequencies in the corresponding cell/tissue type but depleted 
in other cell/tissue types, validating the cell/tissue-specificity of these cRE-
promoter pairs. Statistical significance of pcHi-C interaction frequencies 
was tested by conducting KS-test between mean of pcHi-C interaction 
frequencies in the matched cell/tissue types (values in diagonal in Fig. 2f) 
and those in other cell/tissue types (values in off diagonal in Fig. 2f).     
In order to investigate cell/tissue-specific activity of cREs connected by 
cell/tissue-specific cRE-promoter pairs, we identified group of cREs that 
are connected by unique cRE-promoter pairs for each cell/tissue type. 
After that, H3K27ac signals were calculated for each cRE across all 
cell/tissue types and these values were normalized by taking z-score 
transformation to obtain relative H3K27ac enrichment signals. The mean 
values of normalized H3K27ac signals were calculated for each group of 
cREs in each cell/tissue type. KS-test was performed between the mean 
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values in the corresponding cell/tissue types (values in diagonal in Fig. 2g)
and those in other cell/tissue types (values in off diagonal in Fig. 2g).     
In order to investigate expression levels of target genes connected by 
cell/tissue-specific cRE-promoter pairs, we first defined a group of genes 
that are connected by unique cRE-promoter pairs more than twice for 
each cell/tissue-type. After that, gene expression levels (FPKM) were 
calculated for each gene across all cell/tissue types. Relative gene 
expression levels were obtained by taking z-score transformation for each 
gene across all cell/tissue types. The mean values of z-score transformed 
FPKM values were calculated for each group of genes in each cell/tissue 
type. KS-test was performed between the mean values in the 
corresponding cell/tissue types (values in diagonal in Fig. 2h) and those in 
other cell/tissue types (values in off diagonal in Fig. 2h).
Comparison between eQTL associations and P-P chromatin 
interactions
In order to assess the enrichment for promoter-promoter pcHi-C 
interactions in the significant eQTL associations, we computed the number
of P-P pcHi-C interactions matched to the significant eQTL associations 
(downloaded on Nov. 10th, 2017). For the tested tissue types (n=13, 
adrenal gland, aorta, dorsolateral prefrontal cortex BA9, hippocampus, 
sigmoid colon, left ventricle, liver, lung, ovary, pancreas, small intestine 
terminal ileum for small bowel, spleen, and stomach for gastric), we 
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considered only the eQTLs that are located within 2.5kb from a TSS of a 
protein coding gene. For accurate comparison, we removed P-P chromatin 
interactions beyond 1Mb in distance to match the range of eQTL 
association, and discarded eQTL associations with distance below 15kb to 
match the valid interaction cutoff. Finally, the significant eQTLs were 
filtered by collecting only the eQTLs within the fragments that involve P-P 
pcHi-C interactions in the corresponding cell/tissue and by removing 
eQTLs that target pseudogenes. Then, the number of filtered significant 
eQTLs that match P-P pcHi-C interactions was counted. The DNA 
fragments that harbor multiple promoters were removed from the 
analysis. For the random expectation, we created a control pool of all P-P 
pairs within the range of 15kb to 1Mb, selected the same number of 
random P-P pairs as used in significant eQTL comparison, and counted the
matched number of random P-P pairs with P-P pcHi-C interactions. The P-P
pcHi-C interactions that exist in any of the tissue/cell type were removed 
from the control interaction pool for the enrichment analysis. In addition, 
to avoid variation caused by the difference in distance between pcHi-C 
interactions and eQTL associations, we created distance matched control, 
in which the number of pcHi-C interactions was stored at the interval of 
40kb, and the same number of interactions was drawn randomly from the 
randomized interaction pool. In addition, the number of randomized 
interactions drawn from each chromosome was matched to the pcHi-C 
interactions. The standard deviation was obtained by permuting the 
37
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
73
74
random expectation with 1,000 iterations and was used to calculate the 
statistical significance. 
Visualization of eQTL-supported P-P and P-O chromatin 
interactions
The pcHi-C interactions that matched significant eQTLs were visualized by 
LocusZoom40. We collected and merged significant and all tested eQTLs 
for each tissue type and extracted the relevant p-values and SNP IDs for a
queried gene. Then, LocusZoom was run with default parameters to show 
the pcHi-C interaction and its eQTL associations surrounding the region.
Experimental validation of enhancer-like function of promoters
H1-hESC was cultured in mTeSR1 medium on Matrigel coated plates33. To 
knockout the core promoter regions of ZNF891 (chr12:133706994) and 
ARIH2OS (chr3:48956862) in H1-hESC, we utilized CRISPR/Cas9 RNP 
method as previously described by Diao, et al.33. Briefly, we used in vitro 
synthesized CRISPR crRNA and CRISPR tracrRNA (IDT) with the sequences 
specified below. 
ZNF891 sgRNAs 5p-1: GCGTCCGTGACGCACAGACC
ZNF891 sgRNAs 5p-2: GACCAGGCCCCTCTGCGGGG
ZNF891 sgRNAs 3p-1: AGGCTGGGGCGCGTGCGTAA
ZNF891 sgRNAs 3p-2: GTGCGTAACGGTGTGTGTTG
ZNF891 genotyping primer 5p: GTCCTCAGTGCCTGCCTC
ZNF891 genotyping primer 3p: CAGCAACAGCAAAACAGAGAAC
ARIH2OS sgRNAs 5p-1: GCTCCCAAAGATGACTCGAG
ARIH2OS sgRNAs 5p-2: GACTCGAGTGGTGAGCCCCG
ARIH2OS sgRNAs 3p-1: GGAGAAGTCATCCAAGAACG
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ARIH2OS sgRNAs 3p-2: CGCTATGACAGAAAGTTCTA
ARIH2OS genotyping primer 5p: CATCTAGGCCCTCTCTCCCT
ARIH2OS genotyping primer 3p: TCAGCAATTTCGTTTCAAAATC
Each of the core promoter was knocked-out by two sets of sgRNA pairs to 
avoid the potential off-target effect caused by CRISPR/Cas9 genome 
editing. The Cas9 recombinant protein was purchased from NEB (Cat 
M0386M) and the Cas9/crRNA/tracRNA was assembled in vitro by 
following the previously described protocol33. The RNP complex was 
electro-transfected into POU5F1-eGFP hESC reporter line with Neon 
Transfection System 10µl kit (ThermoFisher Scientific, Cat#: MPK1096) 
with the default electrotransfection protocol. Seven days after post-
transfection, individual colonies were picked and expanded, followed by 
genotyping and in-depth analysis. After genotype validation, we 
performed RNA-seq using Ovation® RNA-Seq System V2 (NuGEN) as 
previously described41.
RNA-seq data analysis between WT and mutants upon promoter 
deletion
Raw RNA-seq fastq files were aligned to the reference genome (hg19) 
using BWA-mem. Duplicate reads were discarded with Picard to avoid any 
artifact caused by the amplification step originated from Ovation® RNA-
Seq System V2 (NuGEN). Then, FPKM values were calculated using 
Cufflinks with GENCODE v19 annotation. Reproducibility between 
biological replicates were measured (PCC of FPKM for WT = 0.98, ZNF891 
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promoter deletion clone #1 =0.99, ZNF891 promoter deletion clone #2 = 
0.99, ZNF891 promoter deletion clone #3=0.99 , and ARIH2OS promoter 
deletion clone #1 =0.98). FPKM values of ZNF84 and NCKIPSD were 
investigated as distal target genes of ZNF891 and ARIH2OS, respectively, 
between mutant and WT to test the effect of deletion of core promoters 
on distal target genes. 
Experimental validation of promoter-proximal eQTL distal target 
genes
In order to validate the distal target genes of promoter-proximal eQTLs 
identified by pcHi-C results, we designed sgRNA sequences targeting +/- 
5bp of the eQTLs in H1-hESC and cloned the sgRNAs into lentiCRISPRv2 
backbone, followed by lentiviral preparation, infection and Puromycin 
selection as previously described33. Two weeks after the infection, single 
clones were selected and genotyped to confirm the mutations on the 
targeted eQTL sites (genotyping PCR results are listed in the oligo file). 
Total RNA was purified from each single clone and subjected to RT-qPCR 
analysis as previously described (Genotyping PCR primers are listed in the
oligo file)33. To conduct statistical analysis, two separate sgRNAs were 
generated, which target the same eQTL. Then, three clones were isolated 
and cultured for a single sgRNA in order to induce the knockout, and each 
of these clones was considered as a biological replicate. Each clone was 
consisted of technical triplicates for the stable measurement of the 
expression during RT-qPCR experiment.
40
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
79
80
chr9:139305041_1 sgRNA in H1-hESC: GCCTTGGGCCGTCGGCGAGGGGG
chr9:139305041_2 sgRNA in H1-hESC: TGGGCCGTCGGCGAGGGGGAGGG
chr17:18128865_1 sgRNA in H1-hESC: GCGGGGCCGGGCCTGCACGGGGG
chr17:18128865_2 sgRNA in H1-hESC: CGCGCGGGGCCGGGCCTGCACGG
chr14:104029246_1 sgRNA in H1-hESC: CGAAGCCCGAGGAAGCGCGGCGG
chr14:104029246_2 sgRNA in H1-hESC: CGGCAGGGTCGCGAAGCCCGAGG
chr3:184032262_1 sgRNA in H1-hESC: GGCAAATCCCATGTGCTCGGCGG
chr3:184032262_2 sgRNA in H1-hESC: GGGGGCAAATCCCATGTGCTCGG
chr9:139305041_F genotyping primer: CGCTGGTAGCCCGACATC
chr9:139305041_R genotyping primer: CCCCGCTTCAGTCGTCAC
chr17:18128865_F genotyping primer: CCCAGTTCACCATTGTCTGG
chr17:18128865_R genotyping primer: AACCGAAACTTCATCATCTTGC
chr14:104029246_F genotyping primer: GAGGCAGCCTGGAGTGAC
chr14:104029246_R genotyping primer: GAGAAAGGTCTTCTTCCCCG
chr3:184032262_F genotyping primer: AATGAACTAAAGAATCGCGGAA
chr3:184032262_R genotyping primer: CACAGACGTAGTCCACAACCAT
Experimental validation of distal target genes for disease-
associated genetic variants
In order to validate the distal target genes of disease-associated genetic 
variants (GWAS-SNPs) identified by pcHi-C results, we designed sgRNA 
sequences targeting +/- 5bp of the GWAS-SNPs in lymphoblastoid cells, 
and cloned the sgRNAs into lentiCRISPRv2 backbone as described above. 
Two weeks after the infection, single clones were selected and genotyped 
to confirm the mutations on the targeted GWAS-SNP sites (genotyping 
PCR results are listed in the oligo file). Total RNA was purified from each 
single clone and subjected to RT-qPCR analysis as previously described 
(Genotyping PCR primers are listed in the oligo file)33. To conduct 
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statistical analysis, two separate sgRNAs were generated, which target 
the same GWAS SNP. Then, two clones were isolated and cultured for a 
single sgRNA in order to induce the knockout, and each of these clones 
was considered as a biological replicate. Each clone was consisted of 
technical triplicates for the stable measurement of the expression during 
RT-qPCR experiment.
chr5.96297527 sgRNA in GM12878: TGCCATTCAGTCTATAGATCTGG
chr17.38032460 sgRNA in GM12878: TGGGCTTTGGCTGGGCGCAGTGG
chr17.38023745 sgRNA in GM12878: GGGCTCCATCCCTACAGAAAAGG
chr3.52707026 sgRNA in GM12878: GAGTTTTGCTCTTATTGTCCAGG
chr3.52703615 sgRNA in GM12878: AGTTATTACAAATAACATCATGG
chr3.52728804 sgRNA in GM12878: TCCTGGAAGATAGCATGCGTGGG
chr3.52706724 sgRNA in GM12878: GGTCTCGAACTCCTGCACTCAGG
chr5: 96297527_F genotyping primer: ACCAGTTTACACGAATCATCCC
chr17:38032460_F genotyping primer: TAGAGACAGAGTTTCGCCCTGT
chr17:38023745_F genotyping primer: TGGGCTCTCTCTACTAACCAGC
chr3:52707026_F genotyping primer: TGACAGCAAGAGAGGAAAGATG
chr3:52703615_F genotyping primer: TCAAATGAAGTTCCAGGAGACA
chr3:52728804_F genotyping primer: ACTTGGTAAGGCAGATGGAGAC
chr3:52706724_F genotyping primer: GTTCAAGTGATTCTCCTGCCTC
chr5: 96297527_R genotyping primer: ACTTCATCATGGGCAGTAAACC
chr17:38032460_R genotyping primer: AGGACCATTCTGTTTTCCTTCA
chr17:38023745_R genotyping primer: GTGACCTTGCTTTAAAAATGGG
chr3:52707026_R genotyping primer: AGGTGGGAGAATTGCTTGAAC
chr3:52703615_R genotyping primer: AACCTGTCAGCTAAGGTTCCAA
chr3:52728804_R genotyping primer: GCAAATTCAACCTAATCCGAAG
chr3:52706724_R genotyping primer: ATGCCTGTAATCCCAACACTTT
Extended GWAS-SNPs with high LD structure
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GWAS-SNPs were obtained from GWAS catalogue database (version1.0.1, 
downloaded on February 2018) and selected with p-value cutoff of 10-5 
with minor manual curations. As GWAS-SNPs obtained from GWAS catalog
database contain tag SNP information only, we extended the GWAS-SNP 
information using linkage disequilibrium (LD) structure. LD scores were 
calculated using PLINK for five different populations obtained from 1000 
genome phase 3 data. For each tag SNP, we included all associated SNPs 
that had tight LD scores (>0.8) across all five populations (AFR, AMR, EAS,
EUR, and SAS). With the p-value cutoff of 10-5, we collected 42,674 
significant GWAS-SNPs across 2,310 GWAS mapped traits and expanded 
this list to 180,893 by including LD information. Then, putative target 
genes of GWAS-SNPs were identified by aggregating all unique pcHi-C 
interactions. We noted that the cutoff value of high LD association is 
arbitrarily determined by considering a stringent cutoff value presented in
a set of previous studies to minimize additional noise in the data analysis. 
Enrichment test of disease genes in putative GWAS-SNP target 
genes
The list of putative disease associated genes was downloaded from 
GeneCard database, obtaining 9,989 disease-associated genes. Then, we 
defined putative target genes of GWAS-SNPs associated with Parkinson 
disease by using pcHi-C interactions or the nearest gene information, 
respectively. Then, we counted the number of matched disease-
associated genes in each set of putative GWAS-SNP target genes. 
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Clustering of GWAS mapped traits based on putative target gene 
similarities
The “mapped traits” were obtained from GWAS catalog database 
(version1.0.1, downloaded on February 2018), and paired with their 
corresponding GWAS SNPs. Then, putative target genes for each GWAS 
SNP were obtained by the unique and aggregated pcHi-C interactions. 
After defining putative target genes and their target frequency for each 
trait, we constructed a 1442 by 1442 correlation matrix where each entry 
indicates a similarity score between the mapped traits in terms of the 
Pearson correlation coefficient (PCC), for which only the traits with a total 
gene count greater than 5 were considered. The correlation matrix was 
subjected to K-means clustering (n=30) using Euclidean distance, and the 
cluster containing ungrouped terms was excluded in further analysis to 
eliminate miscellaneous terms. To avoid having a predetermined number 
of clusters, the remaining 687 traits were rearranged in a correlation 
matrix in terms of their hierarchical relationship (Pearson uncentered and 
complete linkage). The final hierarchically clustered correlation matrix 
showed a clear organization of 40 clusters with a threshold of dendrogram
height, 0.9. Fig. 4c was drawn by using the nearest gene of GWAS SNPs. 
After defining the list of nearest genes for each mapped trait, we again 
measured the similarity between the mapped traits by calculating the 
Pearson correlation coefficient. We presented similarity values between 
the mapped traits as in the same order of mapped traits in Fig. 4b. 
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Similarly, Fig. 4d was drawn by using the GWAS SNPs alone. We measured
the similarity of the mapped traits by calculating the Pearson correlation 
coefficient between GWAS SNPs of each trait, and presented the values as
in the same order of mapped traits in Fig. 4b.
Analysis of functional enrichment using DAVID
To identify the enriched biological pathways in the GWAS mapped traits 
for the clusters, we extracted putative target genes associated with each 
cluster. Then, we performed Gene Ontology (GO) analysis using DAVID 
(6.8 version) to obtain the list of enriched biological pathways for each 
cluster with a cutoff p-value of 10-3 by using the GO_BP annotation 
selection. After that we constructed 40 (number of clusters) by 126 
(number of GO_BP annotations) matrix where each entry indicates 
-log10(p-value) of corresponding GO_BP annotation. Next, we performed 
hierarchical clustering in respect to the enriched biological pathways by 
Pearson correlation matric and average linkage parameter. In 
Supplementary Table 17, we presented GO_BP annotation information.
To see the effect of multiple TSS co-existing in a DNA fragment during 
gene set enrichment analysis, we calculated the number of genes that are
located in the defined DNA fragments for all genes and the genes in 
cluster 38. To see the effect of fragment-sharing TSS of genes on the 
enriched biological pathways, we submitted the genes in cluster 38 for 
enriched pathway analysis using three different queries; 1) total genes in 
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the cluster, 2) random selection of genes in case of fragment-sharing, and
3) after removal of the fragment-sharing genes, as illustrated in 
Supplementary Table 18. We did not observe any significant effect on 
gene set enrichment analysis caused by promoters shared by the same 
HindIII fragment with at least one other promoter. 
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Figure Legends
Figure 1. Genome-wide mapping of promoter-centered chromatin 
interactions in diverse human tissues and cell types.
a, A schematic of the pcHi-C procedure. b, Barplots of normalized 
promoter-centered chromatin interaction frequencies (y-axis) emanating 
from the ADAMTS1 promoter (translucent gray). The identified chromatin 
interactions are shown below the axis (purple loops). Highlighted in 
translucent yellow are cell/tissue type specific interactions. c, Barplots of 
the number of chromatin interactions that span a given genomic distance 
are shown. Orange line indicates the accumulated fraction of chromatin 
interactions from all 27 tissues/cell types. d, Boxplots showing the fold 
enrichment of the interaction frequencies between the active (colored 
dots) or bivalent promoters (gray dots) and each chromatin state. The 17 
chromatin states shown were obtained by processing 18-state ChromHMM
model after merging genic enhancer 1 and 2 annotations. KS-tests were 
performed between interactions originating from active promoter regions 
(colored dots) and those from bivalent promoters (gray dots) (** p value <
0.01 and *** p value < 0.001). The chromatin states that interact more 
frequently with active promoters than bivalent promoters were 
highlighted in translucent yellow. The chromatin states that interact more 
frequently with bivalent promoters than active promoters were 
highlighted in translucent blue. Whiskers correspond to the highest and 
lowest points within 1.5× the interquartile range. 
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Figure 2. Inference of target genes of cis-regulatory sequences 
from pcHi-C data. 
a, Illustrative LocusZoom plot of eQTLs for VLDLR (top) and pcHi-C 
interactions originating from the VLDLR promoter region in aorta tissue 
(bottom). Dots along the LocusZoom plot represent the P-values of SNPs’ 
association with VLDLR gene expression levels in the aorta (data obtained 
from GTEx). Dots are also color-coded based on their Linkage 
Disequilibrium (LD) scores with a tagging SNP. The blue bars indicate the 
recombination rate. b, Barplots showing fold enrichment between the 
number of eQTL-associations matched to P-O pcHi-C interactions and that 
of distance matched random P-O pcHi-C interactions for 12 corresponding 
tissue types. P-O interactions in all 12 tissues were significantly enriched 
for eQTL associations (empirical p value < 0.01). The dotted line indicates 
the expected fold-enrichment (i.e. 1). Error bars indicate standard 
deviation obtained by 1,000 random trials. c, An illustrative example of 
tissue specifically expressed gene, showing positive correlation between 
the chromatin state (H3K27ac) at a distal cRE and expression levels (RNA-
seq) of the promoter connected by long-range chromatin interactions. The
significant chromatin interaction between the POU3F3 promoter and a 
distal cRE marked by H3K27ac ~350kb upstream in hippocampus (HC) 
tissue is shown at the top. Shown below are H3K27ac signals and 
locations of genes. The bar plots at the lower half show the H3K27ac 
signals at the distal cRE (left), the transcript levels of the POU3F3 
(middle), and the normalized pcHi-C interaction frequencies between the 
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POU3F3 promoter and the distal cRE (right). d, Boxplots illustrating the 
H3K27ac signals after quantile normalization at the cREs exhibiting 
hippocampus specific pcHi-C interactions with putative target promoters. 
These cREs are marked by higher levels of H3K27ac in hippocampus than 
in other cell/tissues types (KS-test p value < 0.005). Whiskers correspond 
to the highest and lowest points within 1.5× the interquartile range. e, 
Boxplots showing transcript levels of the putative target genes predicted 
by hippocampus specific pcHi-C interactions. Genes are significantly 
expressed in hippocampus compared to other cell/tissues types (KS-test p 
value < 0.005) except dorsolateral prefrontal cortex (KS-test p value 0.27)
and mesenchymal stem cell (KS-test p value 0.02). Whiskers correspond 
to the highest and lowest points within 1.5× the interquartile range. f-h, 
Heatmaps demonstrate the enrichment of pcHi-C interactions for 
cell/tissue-specific cRE-promoter pairs (column) in the corresponding 
cell/tissue type (row) (f), z-score transformed H3K27ac signals (column) at
the promoter associated cREs (row) (g), and z-score transformed FPKM 
values (column) of RNA-seq at the cREs’ putative target genes (row) (h). 
Color indicates mean values of distance normalized pcHi-C interaction 
frequencies for H1 (n=5,096), MES (n=3,380), MSC (n=5,188), NPC 
(n=1,295), TB (n=5,830), HC (7,100), FC (n=15,733), IMR90 (n=5,313), 
LG (n=1,101), LI (n=2,656), PA (n=2,751), SB (n=1,072), TH (n=2,233), 
GA (n=1,511), LV (n=1,501), PO (n=865), RV (n=1,049), SX (n=9,228), 
AD (n=1,998), AO (n=4,407), and LCL (n=10,283) (f), z-score transformed
H3K27ac signals for H1 (n=5,813), MES (n=3,951), MSC (n=5,790), NPC 
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(n=1,631), TB (n=6,616), HC (7,712), FC (n=15,389), IMR90 (n=6,146), 
LG (n=1,345), LI (n=3,224), PA (n=3,211), SB (n=1,310), TH (n=2,717), 
GA (n=1,903), LV (n=1,741), PO (n=1,087), RV (n=1,296), SX (n=10,077),
AD (n=2,342), AO (n=5,179), and LCL (n=10,945) (g), and z-score 
transformed FPKM values for H1 (n=1,589), MES (n=1,024), MSC 
(n=1,587), NPC (n=450), TB (n=1,920), HC (2,339), FC (n=4,830), IMR90 
(n=1,743), LG (n=310), LI (n=870), PA (n=845), SB (n=293), TH (n=747), 
GA (n=460), LV (n=368), PO (n=281), RV (n=295), SX (n=3,054), AD 
(n=550), AO (n=1,381), and LCL (n=3167) (h). KS-test was performed 
between pcHi-C interaction frequencies, z-score transformed H3K27ac 
signals, and z-score transformed FPKM values in the matched cell/tissue 
types (values in diagonal in each heatmap) and those in other cell/tissue 
types (values in off diagonal in each heatmap), demonstrating significant 
association of cRE-promoter pairs with cell/tissue-specific cRE H3K27ac 
signals and gene expression (KS-test p value < 2.2e-16).   
Figure 3. Enhancer-like promoters involved in regulation of distal 
target genes. 
a, Browser snapshots of the TMED4 locus showing H3K27ac signals and 
promoter-centered chromatin interactions. Shown at the RefSeq genes 
(top), H3K27ac histone modification signals as measured by ChIP-seq 
(middle) and promoter-centered chromatin interactions detected from 
pcHi-C experiments (bottom). Highlighted in translucent blue are 
promoter-promoter pairs showing highly correlated H3K27ac signal and 
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significant pcHi-C interactions. Highlighted in gray is an adjacent promoter
of the TMED4. Shown below are Pearson correlation coefficient (PCC) 
values based on H3K27ac signals and links based on pcHi-C interactions, 
with MSC as the acronym for mesenchymal stem cell. b, Density plots 
showing distributions of PCC values of H3K27ac (blue, median of 
PCC=0.45, n=48,893), H3K4me1 (orange, median of PCC=0.67, 
n=48,893), and H3K4me3 (green, median of PCC=0.64, n=48,893) signals
for P-P pcHi-C interactions. As a control, a density plot of PCC distributions 
of H3K27ac signals for randomly selected promoter-promoter pairs is 
shown (gray, median of PCC=0.02, n=48,142). X-axis indicates PCC of 
histone modification signals between promoter-promoter pairs across 27 
cell/tissue types. c, A pie chart showing the fraction of unique P-P 
interactions matched by eQTL associations, of which 5.7% are P-P 
interactions (n=1,976) in 12 matched tissue types (n=34,880). d, An 
illustrative LocusZoom plot of eQTLs for DACT3 gene expression in 
dorsolateral prefrontal cortex. Both the DACT3 gene promoter region and 
the AP2S1 gene promoter that contains significant eQTLs are highlighted 
in translucent orange, dots along the LocusZoom plot represent SNPs, and
their significance of association with the DACT3 gene expression is plotted
along the left y-axis. Dots are also color-coded based on their LD score 
with a tag SNP (rs78730097). The blue line indicates the estimated 
recombination rate, as plotted along the right y-axis. Gene expression 
levels detected by RNA-seq and RefSeq genes are plotted below the 
LocusZoom plot. e, Illustrative genome browser snapshot of RNA-seq 
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results between control and mutant clones with deletion of the core 
promoter regions of the ARIH2OS. In both control and mutant cells, the 
ARIH2OS gene was not expressed, but the expression of the NCKIPSD 
gene, which displays chromatin interactions with the ARIH2OS gene 
promoter, was significantly down-regulated in the mutant clones (FDR 
adjusted p value from cuffdiff = 0.02). f, Genome browser snapshot 
showing the promoter containing an eQTL targeted by sgRNAs and its 
distal target gene, ABCF3, together with H3K27ac and chromatin 
accessibility (DNaseI). The relative mRNA expression levels of the ABCF3 
quantified by RT-qPCR are shown below, which were significantly down-
regulated in both mutants (*** one-tailed KS-test p value < 0.001). Error 
bars indicate standard deviation of three mutant clones with technical 
triplicates. 
Figure 4. Analysis of human diseases and physiological traits 
based on the putative target genes of GWAS-SNPs. 
a, Genome browser snapshot showing multiple cREs harboring GWAS-
SNPs and their common target gene, NT5DC2, together with signals of 
H3K27ac (ChIP-seq) and chromatin accessibility (DNaseI). The DNA 
fragments containing all these cREs interact with the NT5DC2 gene 
promoter region as evidenced by pcHi-C analysis (arcs). The relative 
mRNA expression levels of the NT5DC2 upon induced mutation of GWAS-
SNPs with sgRNA were quantified by RT-qPCR as shown below. Error bars 
indicate standard deviation of two mutant clones with technical triplicates 
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(KS-test, ** p value < 0.01, *** p value < 0.001). b, Hierarchical clustering
of human diseases and traits based on similarities of the putative target 
genes of trait-associated SNPs and SNPs in LD. The color intensity of each 
dot indicates Pearson correlation coefficient (PCC) of the putative target 
genes between two diseases or traits. Color bars on the left and top 
demarcate the clusters. c, d, Shown are similarities, as measured by 
Pearson correlation coefficient (PCC), between traits in the same order as 
Fig. 4b, based on either the nearest genes of the GWAS SNPs (c) or the 
GWAS SNPs alone (d). The color intensity of each dot indicates PCC of 
target gene similarities between two traits. e, Hierarchical clustering of 
GO biological processes (each column, n=126) for the trait clusters 
defined in Fig. 4b (each row, n=40). Each entry indicates –log10(p-value) 
value of GO biological processes in the corresponding cluster. Several 
representative biological processes are highlighted.
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Extended Data Figure Legends
Extended Data Figure 1. Capture Hi-C design, probe synthesis, 
and target enrichment workflow.
a, Schematic of probe design for Promoter Capture Hi-C experiments. For 
each promoter (black rectangle), two flanking HindIII cut sites were 
identified. A 15bp buffer was then added to each side of the HindIII cut 
site, followed by allocation of three 120-mer capture probes to the same 
sites, with a 30bp shift between the adjacent probes. In total, 12 capture 
probes were designed for each promoter and all probes were targeted to 
the Watson Strand. b, Schematic workflow of custom RNA probe 
synthesis. Single stranded DNA (ssDNA) probe synthesis by CustomArray, 
Inc., is shown from top to bottom; PCR amplification with SP6 recognition 
sequence completion and purification, BsrDI digestion and purification, in 
vitro transcription in the presence of biotinylated UTP and purification, and
pooling of probe batches using equal mass ratios. c, Schematic workflow 
of target enrichment of Hi-C libraries (Promoter Capture Hi-C). From top to
bottom, preparation of library mix, hybridization buffer, and probe mix, 
followed by combining the mixes and overnight incubation to bind probes 
to Hi-C template. Then, preparation of streptavidin beads and wash 
buffers, followed by binding of RNA:DNA duplexes to streptavidin beads 
and rigorous washing to remove off-target binding. And lastly, PCR 
amplification of the resulting Promoter Capture Hi-C library. 
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Extended Data Figure 2. Overview of samples and capture probe 
quality control. 
a, Schematic overview of cell and tissue types analyzed by Promoter 
Capture-Hi-C and note of other datasets available for these samples. 
Embryonic or embryonic-derived cell types are on the left and tissues are 
tabled on the right according to their developmental origin. b, Bar plots 
showing the fraction of number of TSS in a DNA fragment. c, Scatter plot 
showing the reproducibility of probe density from RNA-seq data between 
two probe synthesis experiments. Each dot on the scatter plot represents 
a single promoter and the value is the aggregated probe density from all 
probes assigned to that given promoter. d, Venn diagram showing the 
number of targeted regions that contain detectable probe density based 
on RNA-seq of the capture probes from each replicate of probe synthesis. 
e, Snapshot of Promoter Capture-Hi-C probe density from RNA-seq 
analysis of the capture probes. Two replicates of probe synthesis and 
subsequent RNA-seq are shown, followed by GENCODE gene annotations. 
f, Zoomed-in snapshot of Promoter Capture Hi-C probe density from RNA-
seq analysis of the capture probes. Below the replicate RNA-seq datasets 
are the HindIII cut sites and GENCODE gene annotations, illustrating that 
the vast majority of probe density is only found around HindIII restriction 
sites flanking promoters. g, h, Histograms of the probe densities 
measured by RNA-seq (x-axis) in each promoter from replicate 1 (g) and 
replicate 2 (h) of probe synthesis. 
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Extended Data Figure 3. General characterization of promoter-
centered long-range interactions. 
a, Identified pcHi-C chromatin interactions across multiple cell/tissue 
types are plotted in Genome Browser, with the darkness of blue 
corresponding to the strength of interactions. RefSeq genes are presented
below the snapshot. b, Fraction of pcHi-C interactions uniquely detected 
in one cell/tissue type (green) or also detected in other cell/tissue types 
(orange). The average fraction of cell/tissue-specific interactions is not 
over-estimated due to the number of tested samples (at 22 samples the 
fraction of cell/tissue-specific interactions reach plateau) and tissue-
heterogeneity (similar trend was observed when we only considered pcHi-
C interactions obtained from cell lines). c, Snapshot of a locus showing 
promoter-centered long-range interactions from pcHi-C data in H1-hESC 
(bottom, purple loops) in the context of TAD annotations (blue rectangles) 
identified from Hi-C data (top, red) in H1-hESC. RefSeq genes are shown 
at the bottom. d, Fraction of P-O pcHi-C chromatin interactions in the 
context of TAD annotations with the respective cell/tissue types. 
Extended Data Figure 4. Validation of Promoter Capture Hi-C 
Interactions.
a, Browser snapshot of the CCL gene cluster, highlighting the similarity of 
promoter-centered interactions from Promoter Capture Hi-C and high 
resolution Hi-C data in IMR90. The top two tracks show histone 
modification signals for H3K4me3 and H3K27ac, followed by RefSeq 
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genes. Below are pcHi-C chromatin in IMR90 (blue loops) and promoter-
centered chromatin interactions from high-resolution Hi-C data in IMR90 
(reddish brown loops). b-e, ROC plots illustrating the prediction 
performance of Promoter Capture Hi-C result for in situ Hi-C loops 
anchored at promoters in lymphoblastoid (b), IMR90 (c), hippocampus (d),
and dorsolateral prefrontal cortex (e). Promoter centered interactions for 
in situ Hi-C loops were considered as true interactions, and ROC plots 
were drawn for the corresponding pcHi-C result. ROC scores are shown in 
the ROC plot. f, ROC plots showing the reproducibility of pcHi-C chromatin
interactions between biological replicates. pcHi-C interactions from one 
replicate were used as true interactions, and ROC plots were drawn for the
other replicate. g-k. Venn diagrams presenting the number of commonly 
identified pcHi-C interactions between biological replicates for 
lymphoblastoid (g), dorsolateral prefrontal cortex (h), mesenchymal stem 
cell (i), lymphoblastoid processed by CHICAGO (j), and GM12878 with 
previously published pcHi-C data18 (k). Hypergeometric p-values are 
shown together. l-m, Illustration of interaction intensity in the replicates 
of lymphoblastoid (l) and mesenchymal stem cells (m), depending on the 
replicate consistency. Whiskers correspond to the highest and lowest 
points within 1.5× the interquartile range.
Extended Data Figure 5. Integrative analysis of long-range 
chromatin interactions with epigenome.
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a, b, Shown are histograms of number of interacting cREs per promoter 
(a) and number of interacting promoters per cRE (b). Y-axis indicates 
frequency of the corresponding value in x-axis. c, Depiction of identified 
long-range promoter-centered interactions across a 0.84Mb locus in 
lymphoblastoid (top). Shown below are histone modification signals 
obtained from ChIP-seq analyses35, as well as accessible chromatin 
regions measured from DNaseI hypersensitivity assay. d, Depiction of 
extensively interacting DNA fragments (EIF) from P-P and P-O interactions,
and transcription factor (TF) binding clusters identified in GM12878 cells 
for the same region shown in Extended Data Fig. 5c. Below are 67 TF 
binding profiles obtained from TF ChIP-seq results performed in GM12878 
cells. Highlighted in translucent blue are overlapping EIF and TF binding 
clusters. EIF was defined in each cell/tissue type by selecting frequently 
interacting DNA fragments with multiple promoters in terms of 0.01 
Poisson p value cutoff. e, f, Bar plots showing the number of P-O EIF 
overlapping with TF clusters compared to random expectation in 
lymphoblastoid (e) and H1-hESC (f). Error bars indicate standard deviation
of expectation values calculated by using typical TF peaked regions (blue) 
and generating random genomic regions (green). Empirical p-value shows 
statistical significance (*** p value < 0.001). g, h, Bar plots showing the 
number of P-P EIF overlapping with TF clusters compared to random 
expectation in lymphoblastoid (g) and H1-hESC (h). Error bars indicate 
standard deviation of expectation values calculated by using typical TF 
peaked regions (blue) and generating random genomic regions (green). 
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Empirical p-value shows statistical significance (*** p value < 0.001). i, An
array of bar plots showing the number of P-O EIF overlapping with super-
enhancers (first bar plot, orange), compared to typical enhancers (middle 
bar plot, blue) and random genomic regions (last bar plot, purple). Error 
bars indicate standard deviation of expectation values obtained by 10,000
permutations. Empirical p-value showed statistical significance for all 
tested cell/tissue types compared to random genomic regions (p value < 
0.0001). 
Extended Data Figure 6. Enrichment of long-range chromatin 
interactions at various chromatin states generated by a 50-state 
ChromHMM model. 
a, Boxplots showing the fold change of interaction frequencies between 
active/bivalent promoters and each chromatin state over expected values.
The 50 chromatin states (E01-E50) were obtained from the 50-state 
ChromHMM model. KS-tests were performed between active promoters 
and bivalent promoters (two adjacent boxplots) (** p value < 0.01 and ***
p value < 0.001). The chromatin states that interact more frequently with 
active promoters than bivalent promoters were highlighted in pink 
asterisk. The chromatin states that interact more frequently with bivalent 
promoters than active promoters were highlighted in blue asterisk. 
Whiskers correspond to the highest and lowest points within 1.5× the 
interquartile range. b, A heatmap showing an emission parameter matrix 
of each chromatin state in which each row corresponds to a different 
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chromatin state and each column corresponds to an emission probability 
of a chromatin mark shown at the top. The pre-calculated emission 
parameter heatmap was downloaded from the 50-state ChromHMM model
established by Roadmap Epigenomics Project.
Extended Data Figure 7. Validation of P-O interactions with eQTL 
associations. 
a-c, Illustrative LocusZoom plots of eQTLs for the HS3ST1 (a), the 
METTL25 (b), and the DAAM1 (c) gene expression in left ventricle, 
dorsolateral prefrontal cortex, and aorta, respectively. RefSeq genes are 
plotted below the LocusZoom plot. Identified pcHi-C interactions are 
shown as loops (purple) in the bottom. d, Array of bar plots showing the 
number of matched eQTL associations between P-O pcHi-C chromatin 
interactions after exclusion of DNA fragment shared promoters and 
random expectation across 14 matched tissue types from GTEx database. 
All P-O pcHi-C interactions are significantly enriched by eQTL associations 
compared to random P-O pcHi-C interactions with or without distance 
match (* empirical p-value <0.05, ** empirical p-value <0.01, *** 
empirical p-value <0.001). Error bars indicate standard deviation of 
random expectation values. e, Density plots showing the number of 
unique eQTLs per P-O pcHi-C interaction fragment and randomized 
interactions. No significant difference between pcHi-C interactions and 
randomized interactions (KS-test p value > 0.05) except pancreas (p value
= 0.02), gastric (p value = 0.009), and lung (p value = 0.03). f, Shown are
64
1495
1496
1497
1498
1499
1500
1501
1502
1503
1504
1505
1506
1507
1508
1509
1510
1511
1512
1513
1514
1515
1516
1517
1518
127
128
boxplots of the distribution of PCC between H3K27ac signals in cRE-
promoter pairs connected by pcHi-C interactions after exclusion of 
multiple fragment spanning cREs (Orange, n=154,055), compared to the 
distribution of random expectation with matched distance (dark gray, 
n=154,055) and without matched distance (gray, n=154,055). We only 
considered P-O pairs where other DNA fragments are marked by H3K27ac 
peaks in at least one cell/tissue type analyzed. We also excluded two 
fragments spanning cREs. KS-test was performed between P-O pairs and 
random control, demonstrating that P-O pairs showed significant positive 
correlation (*** Welch’s t-test p value < 2.2e-16). Whiskers correspond to 
the highest and lowest points within 1.5× the interquartile range. g, 
Similar to Extended Data Fig. 7e, but the distribution of PCC between 
H3K27ac signals at a cRE and target gene expressions of the cRE 
connected by pcHi-C interactions. KS-test was performed between P-O 
pairs (orange, n=154,055), distance matched random control (dark gray, 
n=154,055), and random control (gray, n=154,055), revealing that P-O 
pairs showed significant positive correlation (*** Welch’s t-test p value < 
2.2e-16). Whiskers correspond to the highest and lowest points within 
1.5× the interquartile range.
Extended Data Figure 8. Functional analysis of promoter-
promoter interactions. 
a, Pie chart showing the fraction of promoter-promoter interactions (P-P) 
among all pcHi-C interactions. The fraction of P-P pcHi-C interactions 
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modestly decrease to 6.5% after excluding fragment that harbor multiple 
promoters. b, An array of bar plots showing the number of eQTL 
associations matched to P-P pcHi-C interactions (left, purple), compared to
random expectation with matched distance (middle, blue) and without 
matched distance (right, light blue). Each bar plot represents analysis of a
different tissue. Error bars indicate standard deviation of random 
expectation values. Empirical p values are shown at the top (* < 0.05, ** 
< 0.01, *** < 0.001). c, d, Illustrative LocusZoom plots of FHOD1 eQTLs 
(c) and POFUT2 eQTLs (d) in left ventricle and aorta, respectively. 
Promoters that contain significant eQTLs and target promoters are 
highlighted in translucent orange. Dots along the LocusZoom plot 
represent SNPs, and their significance of association with FHOD1 and 
POFUT2 gene expression is plotted along the left y-axis, respectively. The 
blue line traveling across the scatterplot indicates the estimated 
recombination rate, as plotted along the right y-axis. RefSeq genes and 
RNA-seq are plotted below the LocusZoom plot. pcHi-C interactions are 
shown as purple in the bottom. e, Bar plot showing the eQTL associations 
between the SNP rs78730097 and surrounding genes, showing the most 
significant association with the distal gene DACT3. Y-axis indicates –
log10(eQTL association p value). f, g, Bar plots showing FPKM values of 
distal target gene expressions upon deletion of core promoter regions of 
the ARIH2OS (f) and the ZNF891 (g). Two biological replicates of one 
mutant clone for the NCKIPSD and two biological replicates of three 
mutant clones for the ZNF84 were measured using RNA-seq, respectively. 
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FDR-adjusted p value obtained from cuffdiff is shown together. N.S 
indicates statistically non-significant. h, Bar plots showing FPKM values of 
two nearby genes of the ARIH2OS and one nearest gene of the NCKIPSD 
(y-axis) upon deletion of core promoter regions of the ARIH2OS. The 
ARIH2, a DNA fragment sharing gene with the ARIH2OS, is excluded. FDR-
adjusted p value obtained from cuffdiff is shown together. Corresponding 
gene name is shown on the top of bar plots. i, The relative mRNA 
expression levels of distal target genes (orange) and nearby genes (gray) 
of promoter-proximal eQTLs quantified by RT-qPCR are shown. Error bars 
indicate standard deviation from total six mutant clones for two separate 
sgRNAs with technical triplicates. One-sided KS-test p values are shown 
together on the top of each bar plot (*** p value < 0.001).
  
Extended Data Figure 9. Identification of target genes of disease-
associated genetic variants. 
a, Illustration of the strategy to identify target genes of each GWAS trait. 
An example result is shown for Alzheimer disease. Both known and novel 
target genes were identified according to literature search. b, Venn 
diagram showing number of target genes by pcHi-C interactions and by 
nearby gene information for the GWAS-SNPs associated with Parkinson 
disease. c, Number of matched disease-associated genes in each group of
target genes identified in Parkinson disease. d, Fraction of distal genes 
(blue) and nearby genes (gray) among the identified target genes of 
GWAS-SNPs based on pcHi-C interactions (left). Expected fraction is shown
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by calculating the fraction of nearby genes when we consider a nearest 
gene over 15kb as a GWAS-SNP target gene (right). e, Barplot showing 
the relative mRNA expression levels of GNL3 upon induced mutation of 
GWAS-SNPs with sgRNA as quantified by RT-qPCR as a control. Error bars 
indicate standard deviation of two mutant clones with technical triplicates.
f, Barplot showing RT-qPCR results of relative target gene expression (y-
axis) between mutant and control. Error bars indicate standard deviation 
of two mutant clones with technical triplicates. The mutants showing 
significant down regulation of target genes are shown in orange (KS-test, 
** p value < 0.01, *** p value < 0.001). sgRNA target GWAS-SNP genomic 
coordinate, rsID, associated disease, distal target gene information, high 
LD SNP on coding region, and related publication PMID information are 
shown together. 
Extended Data Figure 10. Analysis of disease-disease 
associations. 
a, Illustration of the strategy to calculate the similarity between GWAS 
mapped traits using target gene similarity information. b, c, Shown are 
similarities, as measured by Pearson correlation coefficient (PCC), 
between traits in the same order as Fig. 4b based on similarities of the 
putative GWAS-SNP target genes without shared promoters (b) and 
without genes located in HLA and HIST locus (c). The color intensity of 
each dot indicates Pearson correlation coefficient (PCC) of the putative 
target genes between two diseases or traits. d, Shown are similarities, as 
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measured by Pearson correlation coefficient (PCC), between traits based 
on the 5 nearest genes of the GWAS SNPs. The color intensity of each dot 
indicates PCC of target gene similarities between GWAS mapped traits. e, 
Bar plots showing the fraction of number of TSS in a DNA fragment 
between all TSS and TSS corresponding genes in cluster 38 of Fig. 4b. 
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Supplementary Tables
Supplementary Table 1. List of cell/tissue types analyzed in this 
study
Supplementary Table 2. Number of processed pcHi-C reads 
Supplementary Table 3. List of P-O interactions
Supplementary Table 4. List of P-P interactions
Supplementary Table 5. Number of significant pcHi-C promoter-
centered interactions
Supplementary Table 6. The list of mean and median distance of 
pcHi-C and eQTL associations in each cell/tissue type
Supplementary Table 7. The numbers and fractions of overlapped 
interactions between replicates
Supplementary Table 8. Total number of extensively interacting 
DNA fragments (Poisson P value < 0.01)
Supplementary Table 9. List of TF ChIP-seq data used to define 
GM12878 TF clusters
Supplementary Table 10. List of TF ChIP-seq data used to define 
H1-hESC TF clusters
Supplementary Table 11. Summary of matched eQTL-associations 
with P-O pcHi-C interactions 
Supplementary Table 12. List of P-O pcHi-C interactions and 
matched eQTL relationships
Supplementary Table 13. Summary of matched eQTL-associations 
with P-P pcHi-C interactions
Supplementary Table 14. List of P-P pcHi-C interactions and 
matched eQTL relationships
Supplementary Table 15. Summary of average number of target 
genes of GWAS-SNPs
Supplementary Table 16. List of putative target genes of GWAS-
SNPs
Supplementary Table 17. List of GWAS mapped traits and 
enriched GO biological processes in Fig. 4b
Supplementary Table 18. Enriched pathway analysis of Cluster 38 
in Fig. 4b
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